9 Ovarian Cancer Clinical Trials in Tampa, FL (2026)

Q: How do I join a clinical trial in Tampa?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Tampa research site will contact you.

Recruiting Ovarian Cancer Studies in Tampa

NCT04590326Recruiting

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

This study is researching an investigational drug called REGN5668 : * alone or, * combined with cemiplimab (also known as REGN2810) or, * combined with both cemiplimab and fianlimab (also known as RE...

Tampa, FLPHASE1612 participantsRegeneron Pharmaceuticals

View Study Details

NCT06276491Recruiting

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

The primary purpose of this study is to determine whether the investigational drug XmAb541 is safe and well tolerated, and to determine an optimal and safe dose(s) for further study. The study will al...

Tampa, FLPHASE1282 participantsXencor, Inc.

View Study Details

NCT06072781Recruiting

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (ICT) in subjects with recurrent LGSOC who have progr...

Tampa, FLPHASE3270 participantsVerastem, Inc.

View Study Details

NCT07213791Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

This is a study of LY4337713 in participants with certain types of cancer that is advanced or has spread. Participants must have cancer with high levels of a protein called fibroblast activation prote...

Tampa, FLPHASE1241 participantsEli Lilly and Company

View Study Details

NCT06787612Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

This study is researching an experimental drug called ubamatamab, also referred to as "study drug". The study is focused on patients who have advanced ovarian cancer. The aim of the study is to see h...

Tampa, FLPHASE2220 participantsRegeneron Pharmaceuticals

View Study Details

NCT05080946Recruiting

Using Aspirin to Improve Immunological Features of Ovarian Tumors

The purpose of the study is to evaluate the effectiveness of aspirin with neoadjuvant chemotherapy for decreasing markers of immune suppression in the tumor at interval debulking surgery, in women wit...

Tampa, FLEARLY_PHASE1100 participantsH. Lee Moffitt Cancer Center and Research Institute

View Study Details

NCT05568680Recruiting

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

This first-in-human (FIH) trial is designed to assess the safety, feasibility, and potential activity of a single intravenous (IV) dose of SynKIR-110 administered to subjects with mesothelin-expressin...

Tampa, FLPHASE142 participantsVerismo Therapeutics

View Study Details

NCT06315491Recruiting

A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer

The purpose of this study is to assess the safety, tolerability, and efficacy of CBX-12 in female subjects with platinum resistant or refractory ovarian cancer at 2 doses; 125 mg/m2 every 21 days or 1...

Tampa, FLPHASE240 participantsCybrexa Therapeutics

View Study Details

NCT05316129Recruiting

Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer

The purpose of this first in human study is to evaluate the safety of treatment with autologous T cells genetically modified to express a CER (chimeric endocrine receptor) targeting the FSHR (follicle...

Tampa, FLPHASE110 participantsH. Lee Moffitt Cancer Center and Research Institute

View Study Details

About Ovarian Cancer Clinical Trials in Tampa

Ovarian cancer originates in the ovaries or fallopian tubes and is often called a "silent killer" due to subtle early symptoms. It is the fifth leading cause of cancer death among women. Treatment typically involves surgery and chemotherapy, with newer targeted therapies showing promise.

There are currently 9 ovarian cancer clinical trials recruiting participants in Tampa, FL. These studies are seeking a combined 1,817 participants. Research is being sponsored by Regeneron Pharmaceuticals, Xencor, Inc., Verastem, Inc. and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ovarian Cancer Clinical Trials in Tampa — FAQ

Are there ovarian cancer clinical trials in Tampa?

Yes, there are 9 ovarian cancer clinical trials currently recruiting in Tampa, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Tampa?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tampa research site will contact you about next steps.

Are clinical trials in Tampa free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tampa studies also compensate for your time and travel.

What ovarian cancer treatments are being tested?

The 9 active trials in Tampa are testing new therapies including novel drugs, biologics, and treatment approaches for ovarian cancer.

Data updated July 17, 2026 from ClinicalTrials.gov